Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
health
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Keding Enterprises Co., Ltd.
Haitian International Holdings Ltd.